Tuesday, October 25, 2011

==Proprietary preparations==

[[Grünenthal|Grünenthal GmbH]], which still owns the patent on Tramadol, has cross-licensed the drug to pharmaceutical companies internationally. Thus, Tramadol is marketed under many trade names around the world, including:
{{Multicol}}

* '''Acugesic''' (Malaysia, Singapore)
* '''Adolonta''' (Spain)
* '''Algifeno''' (Bolivia)
* '''Algesia''' (Philippines)
* '''Anadol''' (Bangladesh, Thailand)
* '''Boldol''' (Bosnia, Herzegovina)
* '''Calmador''' (Argentina)
* '''Campex''' (Pakistan)
* '''Contramal''' (Belgium, France, India, Italy, Turkey, Sudan)
* '''Crispin'''
* '''Dolcet''' (combined with paracetamol)(Philippines)
* '''Dolol''' (Denmark)
* '''Dolzam''' (Belgium, Luxembourg)
* '''Dromadol''' (United Kingdom)
* '''Exopen''' (South Korea)
* '''Ixprim''' (France, Ireland)
* '''Lumidol''' (Bosnia, Herzegowina, Croatia)
* '''Mabron''' (Bahrain, Bangladesh, Bulgaria, Czech Republic, Estonia, Iraq, Jordan, Latvia, Lithuania, Malaysia, Oman, Romania, Singapore, Slovakia, Sri Lanka, Sudan, Yemen)
* '''Mandolgin''' (Denmark)
* '''Mandolgine'''
* '''Mosepan'''
* '''Matrix''' (combined with [[paracetamol]]) (Honduras, Guatemala)
{{Multicol-break}}
* '''Nobligan''' (Argentina, Denmark, Iceland, Mexico, Norway, Portugal, Sweden)
* '''Osteodol''' (India)
* '''Oxxalgan PR''' (Greece)
* Palitex (India)
* '''Poltram''' (Poland)
* '''Pyredol''' (combined with [[paracetamol]]) (Vietnam, Bolivia)
* '''Ralivia''' (Canada)
* '''Ryzolt''' (United States)
* '''Sinergix''' (combined with [[ketorolac]]) (Mexico)
* '''Sintradon''' (Serbia)
* '''Siverol''' (Philippines)
* '''Tandol''' (South Korea)
* '''Tiparol''' (Sweden)
* '''Tonoflex''' (Pakistan)
* '''Topalgic''' (France)
* '''Tradol''' (Bangladesh, Ireland, Mexico, Singapore, Venezuela)
* '''Tradolan''' (Austria, Denmark, Finland, Iceland, Romania, Sweden)
* '''Tradolgesic''' (Thailand)
* '''Tradonal''' (Belgium, Indonesia, Italy, Luxembourg, Netherlands, Philippines, Spain, Switzerland)
* '''Tralgit''' (Czech Republic, [[Georgia (country)|Georgia]], Romania, Slovakia)
* '''Tralodie''' (Italy)
* '''Tramacet''' (combined with [[paracetamol]]) (Canada, Mexico, Costa Rica, South Africa)
* '''Tramacip''' (India)
* '''Tramadex''' (Israel)
* '''Tramadin''' (Finland)
* '''Tramadol HEXAL''' (Denmark, Finland, Germany)
* '''Trexol''' (Mexico)
* '''Trumen''' (Bangladesh)
{{Multicol-break}}
* '''Tramadol''' (Australia, Belgium, Canada, Chile, Estonia, France, Netherlands, Romania, New Zealand, Norway, Spain, United Kingdom, United States)
* '''Tramadol Stada''' (Sweden)
* '''Tramadolor''' (Austria, Estonia, Germany, Hungary, Latvia, Lithuania, Luxembourg, Romania)
* '''Tramagit''' (Romania)
* '''Tramahexal''' (Australia)
* '''Tramake''' (United Kingdom)
* '''Trama-Klosidol''' (Argentina)
* '''Tramal''' (Pakistan, Netherlands, Finland, Croatia, Morocco, Slovenia, Austria, Poland, Brazil, Chile, Romania, Australia, New Zealand, Germany, Switzerland, Lebanon, Israel, Philippines, Egypt, Thailand)
* '''Tramalgic''' (Hungary)
* '''Tramal Gotas''' (Ecuador)
* '''Tramazac''' (India, Myanmar, Sri Lanka)
* '''Tramed'''
* '''Tramedo''' (Australia)
* '''Tramoda''' (Thailand)
* '''Tramól''' (Iceland)
* '''Tramundal''' (Austria)
* '''Tridol''' (South Korea)
* '''Tridural''' (Canada)
* '''Trodon''' (Serbia)
{{Multicol-break}}
* '''Ultracet''' (combined with [[paracetamol]])
* '''Ultradol''' (Bangladesh)
* '''Ultram''' and '''Ultram ER''' (United States)
* '''Ultramed''' (combined with [[paracetamol]]) (India)
* '''Veldrol''' (Mexico)
* '''VAMADOL PLUS''' (India)
* '''Volcidol''' (Thailand)
* '''Zafin''' (combined with [[paracetamol]]) (Chile)
* '''Zaldiar''' (combined with [[paracetamol]]) (Belgium, Chile, Croatia, the Czech Republic, Mexico, Poland, Portugal, Slovenia, Spain, Russia)
* '''Zaledor''' (combined with [[paracetamol]]) (Chile)
* '''Zamadol''' (United Kingdom)
* '''Zamudol''' (France)
* '''Zodol''' (Chile, Ecuador, Peru)
* '''Zydol''' (United Kingdom, Ireland, Australia)
* '''Zytram''' (Canada, Iceland, New Zealand, Spain)
* '''Zytrim''' (Spain)
{{Multicol-end}}

No comments:

Post a Comment